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Middle EarMass Causing Vertigo and Facial NerveWeakness
Aron Kandinov, BS; Matthew Smith, MD; Syed F. Ahsan, MD
An elderly woman presented with 2 episodes of vertigo lasting a few minutes while sta-
tionary over 1 day and a several-year history of right-sided hearing loss. She had not expe-
riencedotalgia, otorrhea, or tinnitus. Physical examination revealedamassobstructing the
right external auditory canal and House-Brackmann grade 2 facial nerve weakness on the
right. Audiogram revealed right-sided moderate to profound mixed hearing loss. Com-
puted tomography revealeda soft-tissuemassemanating fromthemiddleear involving the
facial canal with surrounding bony erosion, including dehiscence of the tegmen, cochlea,
bony labyrinth, lateral semicircular canal, and jugular foramen.Thepatientunderwent trans-
temporalmastoidectomyanddebulking.However, owing to themass’s vascularity and sig-
nificant bleeding, the operation was aborted, and she was sent for embolization (Figure,
A).Magnetic resonance imagingduringembolization revealed intenseenhancement in the
right middle ear extending from the epitympanum to the hypotympanumwith extension
into the right external auditory canal (Figure, B). She returned to the operating room, and
the vascular mass was found to extend inferiorly to the jugular bulb and carotid and ante-
riorly into the eustachian tube. Themasswas adherent to the underlying bone and had in-
vaded the facial canal but not the nerve itself. Bothmalleus and incuswere eroded. Immu-
nohistochemical stains of the specimen indicated cells positive for synaptophysin with a
sustentacular pattern of cells positive for S-100 (Figure, C and D).
Intraoperative photographA Axial MRI imageB
Histopathologic imageC Histopathologic imageD
Figure. A, Mastoidectomy, visualization of vascular mass. B, T1-weighted axial magnetic resonance image
(MRI) showing enhancement of right middle ear extending to external auditory canal. C, Hematoxylin-eosin,
original magnification ×40. Clusters of cells surrounded by vascular tissue. D, Synaptophysin stain, original
magnification ×40. Nests of strongly staining neuroendocrine cells separated by vasculature.
WHAT IS YOURDIAGNOSIS?
A. Middle ear paraganglioma
B. Facial nerve hemangioma
C. Facial nerve schwannoma
D. Middle ear adenoma
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Diagnosis
A.Middle ear paraganglioma
Discussion
Middleearparagangliomasareparasympatheticneoplasmsofnaturally
occurringparaganglionicbodies.Paragangliomasareslow-growing, in-
vasive,vascularizedneoplasmsarisingfromeitherthemiddleearorthe
jugular bulb, with a small percentage derived from the facial nerve.1
Middleearparagangliomaspredominate inwomen,usuallypresenting
inthefifthandsixthdecadeswithbiphasicpeaks inthefourthandsev-
enthdecades.2,3Thoughmostgounreported,theincidenceofheadand
neckparagangliomashasbeenestimatedat 1per 100000.2,4Mostof
thesearesporadic,although10%to30%arefamilialandassociatedwith
mutations in the succinatedehydrogenase complex.3,5
The hallmark presentation for middle ear paraganglioma in-
cludes pulsatile tinnitus (81%-90%), hearing loss (77%-81%), and
aural fullness (12%-71%).6,7 They often abut or invade nearby cra-
nial nerves, with patients occasionally presenting with facial pare-
sis (0%-3%), dysphasia, hoarseness, and even shoulder or tongue
weakness.6,7 Physical examination may reveal a fleshy redmass in
the middle ear that blanches secondary to pressure from pneu-
maticotoscopy (Brownsign).Biopsy is contraindicatedowing to the
mass’s vascularity and possible catecholamine secretion.
Parasympathetic paragangliomas in general have a low inci-
dence of catecholamine secretion, with only 1% to 3% of patients
presenting with symptoms of catecholamine excess.3,8 Patients
should nevertheless be questioned regarding symptoms of cat-
echolamine secretion such as palpitations, headaches, and hyper-
tension. While all suspicions for middle ear paraganglioma should
be tested for urinemetanephrine and vanillylmandelic acid preop-
eratively,positive results shouldprompt investigation forpheochro-
mocytomaowingto the low incidenceof functionalglomustumors.2
Serum epinephrine and norepinephrine levels are also useful in di-
agnosis,asparasympatheticparagangliomas lacktheenzymepheny-
lethanolamine N-methyltransferase, which converts norepineph-
rine to epinephrine in their sympathetic counterparts.
Computed tomographywith contrast classically demonstrates
a homogeneous mass with intense enhancement, and is particu-
larly sensitive for signs of bony involvement. Magnetic resonance
imaging with gadolinium enhances soft-tissue detail, resulting in a
lower false-negative rate9 and better delineating dural and neuro-
vascular involvement.Magnetic resonance imagesdemonstrateT1-
isointense signaling and T2-hyperintense signaling with a possible
“salt andpepper”pattern in larger lesionsowing to flowvoids.8Mag-
netic resonance angiography can further delineate the relationship
to thecarotidartery, sigmoid sinusand jugularbulb, and identifypo-
tential blood supply—often the ascending pharyngeal artery in the
case of jugular bulb paragangliomas. The differential diagnosis for
a vascular lesion near the geniculate ganglion includes facial nerve
hemangioma, which also presents with significant facial nerve pa-
resis and bony erosion disproportionate to its size.
Histologically, paragangliomas present as nests of chief cells—
polygonal cells with round nuclei and granular, eosinophilic cyto-
plasm—surrounded by spindle-shaped sustentacular cells in a
Zellballen pattern.3 Higher-grade tumors have been shown to pro-
gressively lose the relationship between the 2 cell types.10 Immu-
nohistochemical stainingof chief cells demonstrates positive stain-
ing for neuroendocrine markers, such as neuron-specific enolase,
synaptophysinand/or chromogranin, andnegative staining forkera-
tins. This lack of keratin immunostaining in paragangliomas distin-
guishes them frommiddle ear adenomas. Sustentacular cells typi-
cally stain positive for S-100.
Middle ear paragangliomas are often locally destructive but
rarely malignant. Although features such as an increase in mitotic
activity, central necrosis and vascular invasion may increase suspi-
cion of malignancy, only metastasis to a lymph node or distant or-
gan confirms malignancy.2 Surgical resection is indicated owing to
their progressive growth pattern and involvement ofmajor vessels
and cranial nerves, although radiotherapy presents a growing
option.6While preoperative embolizationmay be helpful in reduc-
ing bleeding, our practice has also found the use of carbon dioxide
laser extremely helpful in achieving hemostasis.
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